Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today welcomed President Trump's proclamation imposing tariffs of up to 100 percent on imported patented pharmaceuticals and active ...
With the assistance of Congressman Wesley Bell, the University of Missouri–St. Louis has received more than $1 million in federal funding to support the launch and advancement of the API Advanced ...
The FDA’s Center for Biologics Evaluation and Research (CBER) granted NanoMosaic’s request for an Advanced Manufacturing Technology (AMT) designation for its Nanoneedle technology for multiplex ...
Beginning January 1, 2026, the company's collagen production will operate out of MPM Medical's 100,000 sq. ft. FDA-registered facility in Mesquite, Texas. The expansion includes advanced collagen ...
Enables Potential MACI Commercialization Outside of the U.S. CAMBRIDGE, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports ...
The US Food and Drug Administration (FDA) has announced increased flexibility for cell and gene therapy (CGT) manufacturers, loosening quality requirements in an effort to expedite patient access. The ...
Tony Lakavage, executive vice president and head of Global External Affairs at the US Pharmacopeia (USP), outlines the key ...
(RTTNews) - Vericel Corporation (VCEL) announced that the U.S. FDA has approved commercial manufacturing of MACI at its new state-of-the-art cell therapy facility in Burlington, Massachusetts. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results